Mar 15, 2023 04:05PM

Jan 30, 2023 04:01PM

Jan 30, 2023 04:01PM

Oct 21, 2022 07:48AM

Oct 21, 2022 07:48AM

Aug 11, 2022 06:30AM

Jul 25, 2022 06:31AM Matinas BioPharma (MTNB) Reports Positive CHMP Opinion for MAT2203

Jul 25, 2022 06:30AM

May 12, 2022 06:30AM

Mar 8, 2022 06:30AM

Jan 25, 2022 06:32AM

Jan 25, 2022 06:30AM

Dec 16, 2021 06:32AM

Dec 16, 2021 06:30AM Matinas BioPharma Announces Unanimous DSMB Approval to Progress into Fourth and Final Cohort of Patients in the EnACT Trial of MAT2203 (Oral Amphotericin B) for the Treatment of Cryptococcal Meningiti

Nov 8, 2021 06:35AM

Oct 21, 2021 07:00AM

Sep 13, 2021 06:02AM

Sep 13, 2021 06:00AM

Aug 10, 2021 06:31AM

May 10, 2021 06:30AM

Mar 29, 2021 06:30AM Matinas BioPharma Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights

Jan 4, 2021 07:04AM

Jan 4, 2021 07:00AM

Nov 20, 2020 07:08AM

Nov 20, 2020 07:00AM

Nov 6, 2020 07:11AM

Nov 6, 2020 07:00AM

Oct 19, 2020 06:33AM Matinas BioPharma (MTNB) Announces Unanimous DSMB Approval to Progress into Second Cohort of Patients in EnACT Study of MAT2203 for Treatment of Cryptococcal Meningitis

Oct 19, 2020 06:30AM

Sep 15, 2020 07:02AM

Sep 15, 2020 07:00AM

Aug 20, 2020 07:03AM

Aug 20, 2020 07:00AM

Aug 10, 2020 04:05PM

May 11, 2020 04:05PM Matinas BioPharma Reports First Quarter 2020 Financial Results and Operational Highlights

Mar 31, 2020 07:07AM

Mar 31, 2020 07:00AM

Mar 9, 2020 06:30AM

Feb 19, 2020 07:11AM

Feb 19, 2020 07:00AM

Nov 15, 2019 09:23AM

Nov 14, 2019 06:02PM After-Hours Movers 11/14: (FTCH) (PHUN) (RH) Higher; (AGRX) (GLOB) (DLB) Lower (more...)

Nov 13, 2019 06:31AM

Nov 13, 2019 06:30AM

Oct 14, 2019 07:00AM

Oct 7, 2019 07:06AM

Oct 7, 2019 07:00AM

Aug 13, 2019 06:46AM

Aug 13, 2019 06:45AM Matinas BioPharma Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Jul 25, 2019 07:43AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All